
Needle-Free Revolution: How ARS Pharma’s Neffy is Changing Allergy Care
In a significant leap forward for medtech innovation, ARS Pharmaceuticals has secured FDA approval for Neffy 1 mg, the first needle-free epinephrine nasal spray designed
Keep track of the latest FDA approvals and regulatory changes impacting the biotech, medtech, and pharmaceutical sectors. Learn how new regulations are influencing healthcare innovation and access to groundbreaking treatments.
In a significant leap forward for medtech innovation, ARS Pharmaceuticals has secured FDA approval for Neffy 1 mg, the first needle-free epinephrine nasal spray designed
Quick Summary •FDA Clearance: LumiThera’s Valeda system becomes the first FDA-approved treatment for dry age-related macular degeneration (AMD). •Technology: Utilizes photobiomodulation (PBM) therapy to stimulate
Pfizer’s Respiratory Syncytial Virus (RSV) vaccine, Abrysvo, recently received FDA approval for use in adults aged 18 to 59 who are at increased risk for
As we move through 2024, the landscape of medical technology and pharmaceutical innovation is being shaped by several high-impact clinical trials. These trials are poised
As we move further into 2024, the medical technology industry continues to innovate at an incredible pace, bringing new devices that improve patient outcomes and
The healthcare landscape in 2024 is poised for significant advancements as key medical devices and therapies await FDA approval. These anticipated approvals hold the potential